Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-14

Clinical Trial Update: Study to Test an Approved Product in the Early Treatment of Migraine (0462-066) [Phase 3]

View source ↗

Summary

A Phase 3 trial update testing an approved product for early treatment of migraine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Approved product for migraine (early treatment)

Snippet

Sponsor: Organon and Co | Conditions: Migraine | Phase 3 | Status: COMPLETED